Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early-stage Colorectal Cancer
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SMITH, S., & NICHOLS, T. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.061 · Cited by 5,250
Permutation inference for the general linear model
Winkler, A. M., Ridgway, G. R., Webster, M. A., Smith, S. M., & Nichols, T. E. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.01.060 · Cited by 3,563
ApoE-4 and Age at Onset of Alzheimer's Disease: The NIMH Genetics Initiative
Blacker, D., Haines, J. L., Rodes, L., Terwedow, H., Go, R. C. P., Harrell, L. E., Perry, R. T., Bassett, S. S., Chase, G., Meyers, D., et al. (1997) · Neurology · doi:10.1212/wnl.48.1.139 · Cited by 479
Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pröschel, M., & Noble, M. (2008) · Journal of Biology · doi:10.1186/jbiol69 · Cited by 316
Research works printed but not linked: 63
- Silberfarb, 1983, Chemotherapy and cognitive defects in cancer patients, Annu Rev Med, 34, 35, 10.1146/annurev.me.34.020183.000343 · DOI · Paper page
- van Dam, 1998, Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy, J Natl Cancer Inst, 90, 210, 10.1093/jnci/90.3.210 · DOI · Paper page
- Schagen, 1999, Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma, Cancer, 85, 640, 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G · DOI · Paper page
- Brezden, 2000, Cognitive function in breast cancer patients receiving adjuvant chemotherapy, J Clin Oncol, 18, 2695, 10.1200/JCO.2000.18.14.2695 · DOI · Paper page
- Ahles, 2002, Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma, J Clin Oncol, 20, 485, 10.1200/JCO.2002.20.2.485 · DOI · Paper page
- Schagen, 2002, Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients, Ann Oncol, 13, 1387, 10.1093/annonc/mdf241 · DOI · Paper page
- Tchen, 2003, Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer, J Clin Oncol, 21, 4175, 10.1200/JCO.2003.01.119 · DOI · Paper page
- Castellon, 2004, Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen, J Clin Exp Neuropsychol, 26, 955, 10.1080/13803390490510905 · DOI · Paper page
- Wefel, 2004, The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial, Cancer, 100, 2292, 10.1002/cncr.20272 · DOI · Paper page
- Donovan, 2005, Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma, Cancer, 104, 2499, 10.1002/cncr.21482 · DOI
- Shilling, 2005, The effects of adjuvant chemotherapy on cognition in women with breast cancer—preliminary results of an observational longitudinal study, Breast, 14, 142, 10.1016/j.breast.2004.10.004 · DOI · Paper page
- Hurria, 2006, A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy, J Am Geriatr Soc, 54, 1119, 10.1111/j.1532-5415.2006.00789.x · DOI
- Bender, 2006, Cognitive impairment associated with adjuvant therapy in breast cancer, Psychooncology, 15, 422, 10.1002/pon.964 · DOI · Paper page
- Jenkins, 2006, A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer, Br J Cancer, 94, 828, 10.1038/sj.bjc.6603029 · DOI · Paper page
- Schagen, 2006, Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients, J Natl Cancer Inst, 98, 1742, 10.1093/jnci/djj470 · DOI · Paper page
- Scherwath, 2006, Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects, Ann Oncol, 17, 415, 10.1093/annonc/mdj108 · DOI
- Hermelink, 2007, Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study, Cancer, 109, 1905, 10.1002/cncr.22610 · DOI · Paper page
- Kreukels, 2008, Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer, Clin Breast Cancer, 8, 80, 10.3816/CBC.2008.n.006 · DOI
- Jim, 2009, Cognitive functioning in breast cancer survivors: a controlled comparison, Cancer, 115, 1776, 10.1002/cncr.24192 · DOI · Paper page
- Stewart, 2008, The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study, Psychooncology, 17, 122, 10.1002/pon.1210 · DOI · Paper page
- Quesnel, 2009, Cognitive impairments associated with breast cancer treatments: results from a longitudinal study, Breast Cancer Res Treat, 116, 113, 10.1007/s10549-008-0114-2 · DOI · Paper page
- Mehlsen, 2009, No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy, Psychooncology, 18, 248, 10.1002/pon.1398 · DOI
- Tager, 2010, The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study, Breast Cancer Res Treat, 123, 25, 10.1007/s10549-009-0606-8 · DOI
- Wefel, 2010, Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer, Cancer, 116, 3348, 10.1002/cncr.25098 · DOI · Paper page
- Ahles, 2010, Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve, J Clin Oncol, 28, 4434, 10.1200/JCO.2009.27.0827 · DOI · Paper page
- Cimprich, 2010, Prechemotherapy alterations in brain function in women with breast cancer, J Clin Exp Neuropsychol, 32, 324, 10.1080/13803390903032537 · DOI · Paper page
- Jansen, 2011, A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients, Support Care Cancer, 19, 1647
- Deprez, 2012, Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning, J Clin Oncol, 30, 274, 10.1200/JCO.2011.36.8571 · DOI · Paper page
- Ganz, 2013, Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance, J Natl Cancer Inst, 105, 791, 10.1093/jnci/djt073 · DOI · Paper page
- Anderson-Hanley, 2003, Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature, J Int Neuropsychol Soc, 9, 967, 10.1017/S1355617703970019 · DOI · Paper page
- Falleti, 2005, The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature, Brain Cogn, 59, 60, 10.1016/j.bandc.2005.05.001 · DOI · Paper page
- Jansen, 2005, A meta-analysis of studies of the effects of cancer chemotherapy on various domains of cognitive function, Cancer, 104, 2222, 10.1002/cncr.21469 · DOI · Paper page
- Stewart, 2006, A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer, Clin Neuropsychol, 20, 76, 10.1080/138540491005875 · DOI · Paper page
- Jim, 2012, Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy, J Clin Oncol, 30, 3578, 10.1200/JCO.2011.39.5640 · DOI · Paper page
- Saykin, 2003, Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological and neuroimaging perspectives, Semin Clin Neuropsychiatry, 8, 201
- Vardy, 2015, Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study, J Clin Oncol, 33, 4085, 10.1200/JCO.2015.63.0905 · DOI · Paper page
- Andreis, 2013, Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients: a pilot study, Support Care Cancer, 21, 583
- Laws, 2002, APOE-epsilon4 and APOE-491A polymorphisms in individuals with subjective memory loss, Mol Psych, 7, 768, 10.1038/sj.mp.4001083 · DOI
- Nathoo, 2003, Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E, Mol Pathol, 56, 132, 10.1136/mp.56.3.132 · DOI · Paper page
- Ahles, 2003, The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy, Psychooncology, 12, 612, 10.1002/pon.742 · DOI · Paper page
- Weintraub, 2009, The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery, Alzheimer Dis Assoc Disord, 23, 91, 10.1097/WAD.0b013e318191c7dd · DOI · Paper page
- Folstein, 1975, “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician, J Psychiatric Res, 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
- Pfeffer, 1982, Measurement of functional activities in older adults in the community, J Gerontol, 37, 323, 10.1093/geronj/37.3.323 · DOI · Paper page
- Cannon, 2007, The PHQ-9 as a brief assessment of lifetime major depression, Psychol Assess, 19, 247, 10.1037/1040-3590.19.2.247 · DOI · Paper page
- Farias, 2008, The measurement of Everyday Cognition (ECog): scale development and psychometric properties, Neuropsychology, 22, 531, 10.1037/0894-4105.22.4.531 · DOI · Paper page
- Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 · DOI · Paper page
- Smith, 2004, Advances in functional and structural MR image analysis and implementation as FSL, Neuroimage, 23, S208, 10.1016/j.neuroimage.2004.07.051 · DOI · Paper page
- Smith, 2002, Fast robust automated brain extraction, Hum Brain Mapp, 17, 143, 10.1002/hbm.10062 · DOI · Paper page
- Andersson, 2016, An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging, Neuroimage, 125, 1063, 10.1016/j.neuroimage.2015.10.019 · DOI · Paper page
- Smith, 2006, Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data, Neuroimage, 31, 1487, 10.1016/j.neuroimage.2006.02.024 · DOI · Paper page
- Rueckert, 1999, Nonrigid registration using free-form deformations: application to breast MR images, IEEE Trans Med Imaging, 18, 712, 10.1109/42.796284 · DOI · Paper page
- Nelson, 2013, New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors, J Pain Symptom Manage, 46, 707, 10.1016/j.jpainsymman.2012.11.005 · DOI
- Cruzado, 2014, Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients, Support Care Cancer, 22, 1815
- Ahles, 2007, Candidate mechanisms for chemotherapy-induced cognitive changes, Nat Rev Cancer, 7, 192, 10.1038/nrc2073 · DOI · Paper page
- Meyers, 2008, How chemotherapy damages the central nervous system, J Biol, 7, 11
- Pinedo, 2007, Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin, J Clin Oncol, 25, 5320, 10.1200/JCO.2007.13.5954 · DOI
- Moris, 2007, Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine, J Neurol, 254, 534
- Hurria, 2006, Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study, J Am Geriatr Soc, 54, 925, 10.1111/j.1532-5415.2006.00732.x · DOI · Paper page
- Concha, 2013, A macroscopic view of microstructure: using diffusion-weighted images to infer damage, repair, and plasticity of white matter, Neuroscience, 276, 14, 10.1016/j.neuroscience.2013.09.004 · DOI
- Billiet, 2018, Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?, Brain Imaging Behav, 12, 64, 10.1007/s11682-016-9665-8 · DOI · Paper page
- Collins, 2009, Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment, Psychooncology, 18, 134, 10.1002/pon.1379 · DOI · Paper page
- Koppelmans, 2012, Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy, J Clin Oncol, 30, 1080, 10.1200/JCO.2011.37.0189 · DOI · Paper page
- Andre, 2017, Prospective pooled analysis of six phase II trials investigating duration of adjuvant (oxaliplatin-based therapy 3 vs 6 months) for patients with stage III colon cancer, J Clin Oncol, 35, LBA1
Metadata
- Authors
- Sales, M. V. C., Suemoto, C. K., Apolinario, D., Serrao, V., Andrade, C. S., Conceição, D. M., Amaro, E., de Melo, B. A. R., & Riechelmann, R. P.
- Venue
- Clinical Colorectal Cancer
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 18
- Issue
- 1
- Pages
- 19-27
- ISSN
- 1533-0028
- Cited by
- 26
- References
- 4
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/00895-8)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.